WE CAN HELP
Book a FREE consultation  
For a free consultation or assistance, please call 020 7730 6666

Hair Loss Blog

Browse by Category

Reality TV star Kim Kardashian West has explained how important her hair is to her self-esteem.

This opinion is shared by many people – both men and women – which may explain why hair loss can be a particularly fraught process for those experiencing it.

Hair and make-up clause

In a video posted on Elle Magazine’s Youtube channel, the 37 year old re-phrases some headlines which have been written about her to make them more honest.

However, she admitted the headline to one article, which read ‘Fear Not, Kim Kardashian’s Hair Will Always Be Done, Per Her Will’, was true:

“Absolutely… I made a section that if I am so out of it that I can’t even communicate… I definitely need my hair, my make-up and my nails done. I want to look as good as possible”. Continues below…

Kim’s hair loss history

Whilst headline-generating hair obviously plays a key role in her image, this quote shows that it is also extremely valuable to Kardashian West on a personal level. This theory is further backed by her endorsement of various haircare brands and regular ‘hair hacks‘ app content. However, another reason the mum of two may be so particular about her hair is because she is believed to have previously experienced various hair loss conditions.

After the birth of her first child – North West – in 2013, Kim Kardashian West was said to have experienced Postpartum Alopecia. This is a common, temporary condition which occurs due to hormonal fluctuations following pregnancy. The extra hair that is hoarded by the body whilst a woman is pregnant then starts to shed around two to four months after giving birth, and causes hair fall diffusely from all over the scalp .

In 2014 a source reported to The Enquirer, “Kim’s so stressed, her hair is falling out”, when referencing her apparent struggles at balancing her marriage to Kanye West with her career – this may may suggest she had another temporary hairloss condition called Telogen Effluvium.

This also presents around three months from its trigger – usually extreme stress or an underlying health issue – and tends to last up to six months. When hair continues to shed after this period it may indicate Chronic Telogen Effluvium. Whilst a common issue and not generally anything to worry about, these can provoke early-onset Female Pattern Hair Loss in genetically-predisposed women, or exacerbate the rate of shedding where it is already present; family matriarch Kris Jenner is believed to have this hereditary condition.

The eldest Kardashian sister has been photographed showing signs of Traction Alopecia, which is generally caused by tight hairstyles and hair extensions, both of which the entrepreneur has regularly experimented with.

While the condition is fully preventable, in severe cases it can cause permanent baldness. Out of concern for her hair, Kardashian explained she was renouncing hair extensions in 2014. However, she later admitted to still wearing tape-in extensions which are not recommended by hair loss experts.

Lastly, the natural brunette regularly experiments with colourful hairstyles, from peroxide blonde to pink. The bleach involved can cause hair to become dry and brittle, putting her at risk of hair breakage.

Belgravia Centre Womens hair loss treatment alopecia areata traction alopecia female pattern baldness hair growth supplementsThe importance of hair

While Kardashian West’s comments to Elle were light-hearted, research continues to reveal the impact of hair when making a first impression, as well as its wider effect on a woman’s self-esteem.

Reports regularly show how much women fret about losing their hair; data compiled by Vision Critical Research revealed 78 per cent of women worry about being affected by thinning hair.

While the subject of hairloss has become less taboo for men in recent years, it still remains an awkward topic for many women. This is despite the fact that rates of women’s hair loss continue to rise, which has also corresponded with an increase in women seeking hair loss treatments.

Belgravia, hair loss specialists will be able to diagnose any conditions present during an online or in-clinic consultation. From there, a tailored treatment plan can be recommended, featuring appropriate formulations of a clinically-proven topical solution, often with a range of supporting products and therapies to ensure every base is being covered. These include Hair Vitalics for Women – Belgravia’s exclusive premium food supplement for healthy hair growth, containing selenium, biotin, zinc and a range of other key nutrients – for those wanting to follow in Kardashian’s supplement-loving footsteps.

This holistic approach also includes on-going support and monitoring from a dedicated advisor, something which many clients find incredibly beneficial. As Female Pattern Hair Loss Treatment client, Sejal says, “This centre have provided an excellent, supporting service, which I am very grateful for“.

Anyone worried about persistent hair fall or unusual patterns of shedding should be aware that there is help available for which getting a professional diagnosis, is a fantastic, pro-active first step.


circ - The Belgravia Centre Hair Loss Clinic - For Men and WomenThe Belgravia Centre

The Belgravia Centre is the leader in hair loss treatment in the UK, with two clinics based in Central London. If you are worried about hair loss you can arrange a free consultation with a hair loss expert or complete our Online Consultation Form from anywhere in the UK or the rest of the world. View our Hair Loss Success Stories, which are the largest collection of such success stories in the world and demonstrate the levels of success that so many of Belgravia’s patients achieve. You can also phone 020 7730 6666 any time for our hair loss helpline or to arrange a free consultation.


Related Stories


A study produced by the Washington University School of Medicine in St Louis, USA, has identified how genetic and lifestyle factors may influence heart health. The findings may have key implications for understanding hair loss.

Blood pressure health doctor nurse medicalNew genes of interest

This study, published in the American Journal of Human Genetics, selected blood pressure as a research criteria because it is a strong indicator of general cardiovascular health.

Cardiologist and co-first author of the study, Lisa de Las Fuentes, emphasises why understanding blood pressure is so important:

“Blood pressure involves everything from how well your heart squeezes, to how well your blood vessels relax, to how well your brain signals your adrenal glands telling your kidneys to hold on to saltwater… It’s a sophisticated and elegant system, and we’re still working to understand it so we can better treat our patients”.

In order to carry out this investigation researchers analysed the smoking status, blood pressure – systolic and diastolic – and genetic makeup of 610,091 participants.

A diverse patient population was selected, including people with European, African, Asian, Hispanic and Brazilian ancestries.

They discovered lifelong smokers with high blood pressure, also known as hypertension, are likely to have a different genetic background to lifelong smokers with normal blood pressure readings.

Furthermore new genes of interest, such as those which are involved with the function and structure of cilia – the short, eyelash-like filaments found  in tissue cells – were identified, which may prove useful when treating hypertension in the future.

The study also linked blood pressure to genes associated with addiction, including alcohol and nicotine dependence. These lifestyle factors have already been linked to exacerbated hair thinning as well as premature Male Pattern Baldness.

Blood pressure and hair loss

A 2007 European Journal of Dermatology report discovered a strong link between high blood pressure and hairloss. Similarly, findings from a study published in 2017 by the University of Bonn revealed that going bald can be an indicator of health conditions, including high blood pressure, heart disease and cancer.

Additionally, a Bangalore study evaluated 1,000 Indian men in the IT sector with hereditary hair loss between the ages of 25 and 35, and found 85 per cent had hypertension. The hair loss clinic researchers who carried out this study hypothesised that ‘metabolic disorders such as coronary heart disease, obesity and hormonal disorders’ could be the basis of Male Pattern Baldness.

This is at odds of the widely recognised understanding regarding the causes of androgenetic alopecia: that an inherited genetic predisposition to the testosterone by-product DHT is the main cause of genetic hair loss in both men and women.

Men's hair vitamins Hair Vitalics for Men Belgravia Centre hair growthFollowing a Greek study which revealed the correlation between Male Pattern Baldness and aortic stiffness, Yorkshire-based GP Tillman Jacobi even suggested re-classifying this common hair loss condition from a cosmetic issue to an indicator of potential medical concerns.

Non-invasive Male Pattern Hair Loss treatment is currently centred around the only two clinically-proven medications for genetic balding, both of which are licensed by the UK’s MHRA and approved by the USA’s FDA, to promote hair regrowth and stabilise shedding. One of these – minoxidil  – when taken in tablet form, is actually prescribed to treat high blood pressure. Its hair growth properties were discovered when people being treated for hypertension noted this side effect. This oral, dose-dependent medication was then developed into appropriate topical formulations to treat hair loss in both men and women.

Though no known contraindications exist with regards hair loss treatments and hypertension, nor hypotension (low blood pressure), it is Belgravia policy to take extra precautions in these circumstances. Based on the patient’s medical profile, level and pattern of shedding, specialists will discuss options for minoxidil use. This will often recommend starting on a lower dose then building up gradually.

In addition to using the key topical and oral drugs mentioned, a variety of supporting hair growth boosters are also included in many bespoke courses for a 360 degree approach to healthy hair growth, scalp care and preventing baldness. These products range from the highly-targeted Hair Vitalics for Men food supplement to home-use LLLT devices such as the HairMax LaserBand.

Whilst using hair loss treatments may help to retain, regrow or prevent male pattern baldness, if an active genetic predisposition is present, this can still be considered a potential bio-marker for underlying health issues – it may simply mean that men will have to admit their condition to their GP if they no longer display the tell-tale visual signs of it.


The Belgravia Centre Hair Loss Clinic - Hair Loss Specialist ConsultationThe Belgravia Centre

The Belgravia Centre is an organisation specialising in hair growth and hair loss prevention with two clinics and in-house pharmacies in Central London, UK. If you are worried about hair loss you can arrange a free consultation with a hair loss expert or complete our Online Consultation Form from anywhere in the world. View our Hair Loss Success Stories, which includes the world’s largest gallery of hair growth comparison photos and demonstrates the levels of success that so many of Belgravia’s patients achieve. You can also phone 020 7730 6666 any time to arrange a free consultation.


Related Stories


S Club 7 and Primeval star Hannah Spearritt has revealed how her 2013 breast enlargement surgery caused numerous issues, including hair loss.

She underwent an ‘explant’ operation to remove her implants three years later, which she says has improved her mental and physical well-being.

Hannah SpearrittThe actor experienced ‘breast implant illness’. According to the Texas-based plastic surgeon Dr Edward Melmed, who carried out Spearritt’s surgery and is quoted commenting on her story in the Daily Mail, this suggests ‘a microscopic seepage of silicone attaches itself to nerve endings in the body’ which results in ‘hair loss, cognitive disorders, chronic fatigue, dry eyes and severe muscle pain’.

Breast implant illness

As reported by Mail Online, the 37 year old – who is now on a mission to raise public awareness of the condition and silicone toxicity – described her ordeal as “the hardest, most traumatic four years“.

Spearritt explained she underwent cosmetic surgery because she always compared herself to other women: “I never felt womanly enough on top. I’d compare myself to the other girls in the band during photoshoots and was jealous of their beautiful curves”.

However, following the operation, she had other concerns as her immune system began to be affected. “Within six months my hair started to fall out in clumps. Then I started sleeping more and more – eventually 22 hours a day,” she told Metro.

Spearritt also appeared on This Morning, telling viewers she started experiencing “crippling anxiety” after her boob job, then further symptoms crept in. “I had hair loss, fatigue, memory loss… I still have some of that. There was a list of symptoms that goes on and on.” 

Speaking on the TV show about having had her implants removed, Spearritt says, “My energy came back in bucket loads, I also had low-grade fever throughout the time I had the implants in, straight away it went back to normal”. 

She and her partner have now set up the Facebook page ‘Breast Implant Illness’ to offer peer support to others who may be affected. This can be found at facebook.com/breastimplantillness

As reported in the medical journal of the American Society of Plastic Surgeons (ASPS), women who experience increased stress are at greater risk of thinning hair. People often assume this to mean the emotional feeling of being stressed, but – though this is entirely correct, as psychodermatologists have shown – there are other physical forms of stress and strain which can cause hair loss. This is especially true in cases of illness, surgery and during periods of high anxiety. Continues below…

Physical and mental strain

From what Hannah Spearritt describes, it appears she most likely experienced Telogen Effluvium, a temporary hair loss condition which may occur following a sudden traumatic event or prolonged stress.

This can be emotional or physical strain, including the distress caused to the body by an illness – diagnosed or underlying, an operation (ironically, even if this is a hair transplant procedure) or adjusting to new medication. As Spearritt detailed experiencing at least two of these triggers, as well as high levels of anxiety – sufficient to cause panic attacks – this, or the Chronic form, is Belgravia specialists’ suspected diagnosis.

TThe Belgravia Centre london clinic Womens hairloss treatmentelogen Effluvium forces hairs from the active growth ‘anagen’ phase, to prematurely enter the telogen (resting) phase of the hair growth cycle, where they remain for around three months before shedding. This is why, despite seeming sudden – as per Spearritt’s description of hair suddenly falling out in clumps – there is a gap between the condition being triggered and hair fall becoming noticeable. This can be shocking when it does happen, given up to 50 per cent of the hairs on a person’s head may be affected.

It causes diffuse hair thinning from all over the scalp and lasts for up to six months in regular cases, with Chronic Telogen Effluvium taking at least six months to clear up. However, anyone noticing this kind of intense hair fall and a noticeable drop in the volume of their hair should consult a specialist as this type of hair loss can be an indicator of other health issues.

For both regular and Chronic Telogen Effluvium, once the body has recovered from the underlying issue, normal hair regrowth will usually resume naturally. However, where required, Telogen Effluvium treatment is possible and may help to accelerate the process, using topical medication and a range of supporting booster products, such as Hair Vitalics for Women – Belgravia’s exclusive food supplement for healthy hair growth, containing selenium, biotin, zinc and a range of additional highly-targeted vitamins, minerals, amino acids and botanical extracts.

For those with a genetic predisposition, Telogen Effluvium may bring about the premature onset of Female Pattern Hair Loss. Or, where this permanent, hereditary hair loss condition is already present, the rate of shedding may be increased. Considering this, a specialist consultation should help to provide an accurate diagnosis, personalised treatment recommendations and valuable peace of mind.


Belgravia Centre Hair Loss ClinicThe Belgravia Centre

The Belgravia Centre is the leader in hair loss treatment in the UK, with two clinics based in Central London. If you are worried about hair loss you can arrange a free consultation with a hair loss expert or complete our Online Consultation Form from anywhere in the UK or the rest of the world. View our Hair Loss Success Stories, which are the largest collection of such success stories in the world and demonstrate the levels of success that so many of Belgravia’s patients achieve. You can also phone 020 7730 6666 any time for our hair loss helpline or to arrange a free consultation.


Related Stories


Professional golfer Tiger Woods has won 14 major championships, the second most in the sport’s history. However, multiple scandals and injuries have blighted his otherwise legendary career.

In April 2017 he underwent surgery on his back for the fourth time. Unfortunately the stresses of medical procedures can sometimes lead to hair loss, not the best news for Woods who has openly discussed his experiences with a receding hairline.

Tiger Woods Thinning Hair Receding HairlineHair loss following surgery

The golfer had his first back surgery in 2014 for a pinched nerve; he had two more operations in 2015 and another in 2017.

When talking to CBS Sports, Woods explained his back issues became so bad that he had to use a golf club as a crutch when getting out of bed. In a video uploaded to the BBC Sport website, the 42 year old labelled himself a “walking miracle” following his most recent procedure, which allowed him to participate at the 2018 Masters tournament.

His evident, and self-confirmed Male Pattern Baldness diagnosis aside, Woods’ frequent brushes with surgery indicate he is at a higher risk of contracting a further hair loss condition.

Telogen Effluvium is a temporary condition which affects the hair growth cycle; it premature forces follicles into the resting – or telogen – phase, leading to diffusely thinning hair from all over the scalp. It can be triggered by severe stress or a sudden shock to the body, including that brought on by surgery or chronic pain.

CBS Sports reported how Tiger Woods touched on his struggles with pain medication during a 2017 press conference. The heavy overuse of painkillers – as well as the regular use of various prescription medications – can also cause hair loss as a side effect. This is also due to Telogen Effluvium though should it present for more than six months, this persistent form of the condition is known as Diffuse Thinning or Chronic Telogen Effluvium. Regular Telogen Effluvium takes around three months post-trigger to appear, it will normally clear up naturally within up to six months, though treatment is available to help expedite this process.

The sportsman’s undoubtedly draining experiences with surgery may also have caused him prolonged psychological stress – yet another trigger of Diffuse Thinning.

Exacerbates thinning hair

Given his existing Male Pattern Baldness, these types of strain – and any additional Telogen Effluvium – may have had negative consequences for Woods’ rate of shedding. This is because additional stressors placed upon the body – mentally or physically – sufficient to cause Telogen Effluvium, can speed up the rate of hair fall in cases of genetic hair loss.

It is entirely possible for both conditions to present simultaneously. For Woods, this would mean the areas affected by Male Pattern Hair Loss becoming, at least temporarily, thinner than usual, with additional hair fall being seen from the back and sides of the scalp – the areas unaffected by DHT.

Since winning his first major tournament in 1997 Woods has gradually been experiencing thinning on top and a receding hairline – typical signs of permanent, hereditary hairloss.

He has been forthcoming when talking about his condition, telling Fox Sports in a 2014 interview regarding getting older: “I’m comfortable with it; my hairline’s not. I have a nice skylight [at home] and, if I don’t wear a hat, I can feel the heat”.

He even joked about losing his hair in his arrest video when he was taken in for being found asleep at the wheel.

Hair restoration

Male Hair Loss treatment, which makes use of MHRA licensed and FDA approved drugs that come in the form of a tablet and a topical solution, can be used to help stabilise shedding, promote regrowth and prevent baldness. At Belgravia these are often used in tandem with hair growth boosters, to ensure every treatment course is highly targeted to the needs of each individual client.

These supporting products and therapies range from devices – such as the FDA-cleared, LLLT-emitting HairMax LaserComb – to premium nutritional supplements: Belgravia’s exclusive Hair Vitalics for Men food supplement contains a range of botanical extracts, amino acids, minerals and vitamins, including biotin, zinc and selenium which help to support healthy hair growth.

For those who have experienced hair loss following surgery, or simply prolonged excessive hair thinning, it may be worthwhile having a scalp assessment with a professional hair loss specialist. They can then provide a diagnosis and recommend a bespoke treatment course to treat single or multiple conditions at once.


The Belgravia Centre Hair Loss Clinic - Hair Loss Specialist ConsultationThe Belgravia Centre

The Belgravia Centre is an organisation specialising in hair growth and hair loss prevention with two clinics and in-house pharmacies in Central London, UK. If you are worried about hair loss you can arrange a free consultation with a hair loss expert or complete our Online Consultation Form from anywhere in the world. View our Hair Loss Success Stories, which includes the world’s largest gallery of hair growth comparison photos and demonstrates the levels of success that so many of Belgravia’s patients achieve. You can also phone 020 7730 6666 any time to arrange a free consultation.


Related Stories


The hair loss process can be tough for those going through it, particularly for young people who may feel alienated and ‘othered’.

In spite of these pressures, 15-year-old student Elisha Appleby has become a brand ambassador for Sunderland-based wig producer Pdollpalace after being recruited by its owner, Jolene Casey.

A line of high-quality synthetic wigs, eponymously named Elisha’s Wigs, is being released in collaboration with the company, and promoted across social media using the hashtag #IAMELISHA.

Cause of hair loss

Hairloss has been a recent phenomenon for Appleby. She spoke to her local North-East newspaper, The Chronicle, about noticing clumps of hair falling from her head around her last birthday.

It continued to shed, taking a heavy emotional toll on the teenager: “As a 15 year old girl, my hair was a priority. I was getting bullied and I locked myself in my bedroom and wouldn’t go to school”.

In a video on the newspaper’s website Appleby explains how she saw a dermatologist who diagnosed her with Alopecia Areata, an autoimmune disorder which causes sudden, patchy hair loss to the scalp.

Medics who assessed her condition believe it was caused by stress as she also experiences severe nose bleeds: Alopecia Areata can be triggered by long-term, chronic psychological stress.

Judging by her pictures, Appleby still appears to have her eyebrow hair and eyelashes, which suggests she may have the scalp-only form of the condition rather than its two more extreme phenotypes – Alopecia Totalis and Universalis. These cause baldness of the entire head, and from head-to-toe, respectively. Though, of course, Elisha may be wearing false lashes and micro-pigmentation eyebrow tattoos.

As a means of coping with her hair loss, the schoolgirl shaved her head and posted the results on Facebook to raise alopecia awareness. She received a lot of support, particularly from Jolene Casey who messaged her afterwards asking her to become a Pdollpalace brand ambassador.

The teenager has been recruiting women with medical hair loss to model her range of wigs and has been inundated with volunteers. She told The Chronicle beforehand, “They can be any age, size, anyone who has suffered hair loss through alopecia, cancer, chemotherapy or hair loss after pregnancy”.

IAMELISHA pdollpalace elishas wigs collection alopecia areata“We want to do a photoshoot, we can all model the Elisha Wigs which will go on the Pdollpalace website… They’ll get a makeover and we will have fun and model all sorts of colours and styles. We want to give the girls the confidence they need. We want people to know bald is beautiful”.

Wigs for children and young people

Unfortunately scalp-only Alopecia Areata treatment is unavailable for those under the age of 16: additionally there are currently no safe and effective treatments for Alopecia Totalis and Alopecia Universalis, though options are in development.

Despite this, Appleby demonstrates that wigs are an excellent source of confidence for young people experiencing hair loss.

In the UK, Little Princess Trust offers free real-hair wigs to girls and young women up to 24 years of age who have medical hair loss, usually from autoimmune alopecia or as a result of cancer treatment. Celebrity endorsements include One Direction star Harry Styles and the Duchess of Cambridge, Kate Middleton, who have both donated their hair to the charity.

The charity’s male division, Hero by LPT was set up in 2017 to offer the same service to young men and boys, also up to 24 years of age. The 2017-18 Premier League champions Manchester City are proud supporters and recently auctioned a signed Sergio Aguero kit to raise money for the charity.

Not everyone who loses their hair wants to wear a wig though, and for those who simply want support in dealing with their condition, hair loss charities such as Alopecia UK can prove invaluable. As Appleby reiterates, “Bald is beautiful and I want everyone to know it”.


Circ - Belgravia Centre Hair Loss Clinics LondonThe Belgravia Centre

The Belgravia Centre is the leader in hair loss treatment in the UK, with two clinics based in Central London. If you are worried about hair loss you can arrange a free consultation with a hair loss expert or complete our Online Consultation Form from anywhere in the UK or the rest of the world. View our Hair Loss Success Stories, which are the largest collection of such success stories in the world and demonstrate the levels of success that so many of Belgravia’s patients achieve. You can also phone 020 7730 6666 any time for our hair loss helpline or to arrange a free consultation.


Related Stories


Dee Armstrong, a much-loved veteran news anchor for the American WLTZ TV station was arrested following a dispute with her son.

After the incident a bald mugshot of the TV personality without her wig went viral on Facebook, revealing her hair loss to a wider audience.

‘Hey Dee, you’re not alone’

Armstrong returned to work nearly a week after the initial event. As reported on the Ledger-Enquirer website, she jokingly commented, “I was eventually going to [talk about losing hair], but they made sure I’m gonna talk about it now”.

The reporter’s hair loss condition is not named, but is described in the article as “hair- thinning and Alopecia“.

When used as a standalone term ‘alopecia’ is a general descriptor for hair loss of any kind, including Androgenetic Alopecia – also known as Female Pattern Hair Loss – Traction Alopecia and Cicatricial Alopecia. As such, it is unclear which specific condition she is experiencing. However, the fact she is now bald, specifically references ‘Alopecia’ and mentioned in the article that she shaved her head, suggests she may have a form of Alopecia Areata.

Judging by her mugshot, it appears Armstrong has not lost her eyebrow hair nor her eyelashes. Given the more severe Alopecia Areata phenotypes, Alopecia Totalis and Universalis, both involve baldness of the whole head – including facial hair – this indicates it is more likely she may have the scalp-only form of Alopecia Areata, though a proper consultation would be required to provide an accurate diagnosis.

The autoimmune disorder Alopecia Areata in this suspected form presents as sudden, patchy hair loss which, when it extends to large areas of the scalp, can be accompanied by thinning hair between the rounded bald spots. This may account for her initial description. There are Alopecia Areata treatment options available for this strain of autoimmune hairloss, which may have been what the popular community figure was exploring when it was reported that she had been speaking to a hair expert in Atlanta about her issues.

Regardless of what had caused her baldness, Dee Armstrong was shocked to see the response of others: “I have had so many women telling me, ‘Hey Dee, you’re not alone” – and she certainly isn’t. A 2017 report conducted by a US-based think tank – the Perception Institute – revealed black women experience higher levels of anxiety about their hair than white women, though women of all races and hair types are increasingly raising concerns regarding increased hair loss.

Women’s hair loss

“One of the hardest things to ever happen to me was to have them post that picture of me… And I wanted to do it on my own terms, you know… when I talk about it I wanted to talk about it the way I wanted to talk about it. But I wasn’t given that option,” says Armstrong.

As she demonstrates, women’s hair loss can be a tricky conversation to have, a topic which is less spoken about than men’s and still has a perceived stigma attached to it which people are gradually working to eradicate. Armstrong did note that she received a lot of help from her local community after the incident: “people were so doggone sweet to me”.

Often becoming informed about a hair loss condition can help to make the process a little easier to manage. Similarly an online or in-clinic consultation with a Belgravia specialist provides a professional diagnosis, advice and personalised treatment recommendations.

A tailored hair loss treatment plan can then be recommended, which typically combines clinically-proven medications and complementary hair growth supporting products, such as the highly-targeted Hair Vitalics for Women food supplement.

Staff ensure clients feel comfortable throughout their course by offering on-going monitoring and support, which has helped many women feel more confident, as documented in the many reviews in Belgravia’s Success Stories gallery. This Belgravia client explained, “I am very pleased with the result. The staff are very friendly and encouraging. I am glad I came. I will recommend it very strongly”.

Armstrong’s experience and her public discussions will hopefully inspire more women to feel comfortable in both talking openly about losing their hair, and seeking help if needed.



circ - The Belgravia Centre Hair Loss Clinic - For Men and Women

The Belgravia Centre

The Belgravia Centre is the leader in hair loss treatment in the UK, with two clinics based in Central London. If you are worried about hair loss you can arrange a free consultation with a hair loss expert or complete our Online Consultation Form from anywhere in the UK or the rest of the world. View our Hair Loss Success Stories, which are the largest collection of such success stories in the world and demonstrate the levels of success that so many of Belgravia’s patients achieve. You can also phone 020 7730 6666 any time for our hair loss helpline or to arrange a free consultation.


Related Stories


An American study has investigated potential treatment for hair loss caused by endocrine therapy for breast cancer patients, with a view to improving the lives of those receiving it.

This research marks the first time endocrine therapy-induced alopecia (EIA) has been officially explored in this way.

A study sponsored by the Memorial Sloan Kettering Cancer Centre in New York is also aiming to explore the impact of cancer treatment on a patient’s quality of life. It has been gathering data from women with breast cancer since 2015.

Tamoxifen breast cancer endocrine induced alopecia hair lossEndocrine-induced alopecia

As noted on the JAMA Dermatology website, the study was carried out from 1 January 2009 to 31 December 2016.

It involved 112 patients with breast cancer who had also been diagnosed with endocrine-induced alopecia. Subjects ranged from 34 to 90 years of age. Findings from the study reported ‘Alopecia was attributed to aromatase inhibitors in 75 patients (67%) and tamoxifen in 37 (33%)’.

The patient’s quality of life was measured using the Hairdex Questionnaire. Despite most cases of EIA being mild, the researchers explained how patients reported a ‘significant negative emotional impact’, testament to the negative psychological effects losing hair can have on women.

Hairloss during cancer treatment, particularly chemotherapy, is usually caused by Anagen Effluvium. However, as this study’s investigators revealed, the appearance of ‘vellus hairs and intermediate- and thick-diameter terminal hair shafts’ suggests the participants’s pattern of hair loss was similar to Androgenic Alopecia, more commonly referred to as Female Pattern Hair Loss.

What exactly is meant by this isn’t specified in the study, though whilst it could refer to the location – genetic hair loss only affects the vertex – it is more likely to be referring to the fact that this hereditary condition causes thinning hair. A common form of temporary hair thinning caused by illness and medications is something called Chronic Telogen Effluvium – something for which treatment is available, though only once the individual patient’s oncologist has given their consent.

Researchers emphasise the role androgens and estrogens, the male and female sex hormones, play in the hair growth process and why endocrine therapy – also known hormone therapy – which adds, blocks or removes hormones, may cause hair loss:

‘When endocrine receptor activation and pathway signaling are blocked, dihydrotestosterone levels increase, and this action may contribute to the induction of alopecia in susceptible women receiving ET [endocrine therapy]’.

Dihydrotestosterone, or DHT, is found to be a key cause of hair shedding in genetically-predisposed individuals. As a result the investigators hypothesise that those receiving endocrine therapy may benefit from current treatments for hereditary hair loss, such as minoxidil.

Minoxidil Dropper with liquidFindings of the study and current options

Of the 46 patients who were assessed for their response to the drug, hair growth was observed in 37. Given the negative correlation between hair loss and quality of life, this medication may improve the lives of women undergoing endocrine therapy in the future.

It must be noted the shedding caused by chemotherapy differs from endocrine therapy-induced hair loss: patients looking to prevent hair loss during treatment, or at least minimise chemo-related hair fall, can often use scalp cooling systems known as cold caps. These chill the scalp to extremely low temperatures which restricts the flood of blood – and thus chemo drugs – to the hair follicles.

Minoxidil is MHRA licensed and FDA approved to treat Female Pattern Baldness. However, results have also been seen when treating other hairloss conditions, including Chronic Telogen Effluvium, Alopecia Areata and Traction Alopecia, with the topical medication.

If concerned about losing hair during hormone therapy then speaking to an oncologist should be the first priority. If wanting to explore hair loss treatment then they can provide a letter of recommendation. At Belgravia an oncologist’s letter of authorisation is always required for anyone who has received cancer treatment.

Hair lost to cancer tends to grow back naturally within 12 months of treatment ending, but for anyone looking for help in accelerating the hair regrowth process, it is advisable to speak to a hair loss specialist who, with the relevant oncologist’s assistance, can provide a suitable solution tailored to the precise needs – including level of shedding and medical profile – of the affected individual.

Larger clinical trials would be needed to prove the efficacy, safety and tolerability of minoxidil when treating endocrine-induced alopecia, and anyone with cancer-related hair loss is advised not to try over-the-counter medications in a bid to regrow their hair, without consulting their doctor or oncologist first.


circ - The Belgravia Centre Hair Loss Clinic - For Men and WomenThe Belgravia Centre

The Belgravia Centre is the leader in hair loss treatment in the UK, with two clinics based in Central London. If you are worried about hair loss you can arrange a free consultation with a hair loss expert or complete our Online Consultation Form from anywhere in the UK or the rest of the world. View our Hair Loss Success Stories, which are the largest collection of such success stories in the world and demonstrate the levels of success that so many of Belgravia’s patients achieve. You can also phone 020 7730 6666 any time for our hair loss helpline or to arrange a free consultation.


Related Stories


Researchers from the Wake Forest University Health Sciences department have announced a clinical trial which seeks to understand whether platelet-rich plasma (PRP) therapy can treat hair loss caused by Androgenic Alopecia – better known as Female Pattern Hair Loss. It will also explore whether this treatment improves the quality of life of the participants.

PRP therapy involves taking blood from a person and re-injecting enriched elements of that blood back into targeted areas, in this case the scalp. It is used as a popular cosmetic treatment – often known as a Vampire Facelift – as a result of its alleged anti-aging properties.

Prior research conducted by the International University of Catalonia in Barcelona revealed it could be useful for treating hereditary hairloss when used in conjunction with clinically-proven treatments.

This interventional study is due to be carried out from May 2018 under the direction of Principal Investigator Rita Pichardo, MD.

Platelet Rich Plasma Therapy (PRP)

A diagram explaining Platalet Rich Plasma Therapy (PRP)

Research criteria

The trial’s official title is registered on the ClinicalTrials.gov website as ‘Evaluating the Efficacy of Platelet-rich Plasma Therapy in the Treatment of Androgenic Alopecia’.

Researchers are recruiting 16 female participants aged 18 years and over who must have proof of an Androgenic Alopecia diagnosis as explained by “one or more clinical features”.

Volunteers cannot be on any hair loss treatment, or have “undergone 2-week washout period if recently on medication(s) for alopecia”.

Exclusion criteria includes being pregnant or breastfeeding, experiencing ‘an infection, metastatic disease or certain skin conditions which could worsen or spread with injectionsor being diagnosed with anaemia, having a blood/bleeding disorder and receiving anticoagulant therapy.

At the first ‘baseline’ visit, the participants will be randomly assigned to either Group A or Group B; while Group A will receive PRP on the left side of the scalp and a placebo injection on the right side, Group B will receive PRP on the right side and a placebo on the left.

Measuring hair regrowth

Treatment visits will take place once every month for three months; a follow-up, non-treatment visit will take place after six months. Trichoscan images will be captured to document clinical progress.

In order to gauge how much PRP improves hair growth and quality of life for the participants, many factors will be analysed throughout the trial. These include: hair count, hair growth, hair density, and readings measured against the Dermatology Life Quality Index (DLQI), the Alopecia Density and Extent Score (ALODEX) and the Severity of Alopecia Tool (SALT).

The team hypothesises that ‘PRP will improve DLQI, SALT, ALODEX, hair count (number of hairs/0.65 cm2), hair density (number of hairs/cm2), hair diameter, anagen to telogen ratio, and vellus hair to terminal hair ratio in female subjects with androgenic alopecia’.

Interestingly, although the trial is investigating Female Pattern Baldness, which is usually measured via the Ludwig Scale, researchers have chosen to use the SALT index which is generally seen when assessing Alopecia Areata.

Useful as a booster?

Despite the rising interest in PRP for hair regrowth, clinical trials have not been able to demonstrate it can effectively treat hair loss in women – or in men. Furthermore, Female Pattern Hair Loss is progressive and will continue to cause thinning hair unless the root cause is dealt with.

PRP injections may be useful as a booster when used alongside clinically-proven medications but they would need to be on-going as genetic hair loss is a permanent condition. However PRP can often be expensive and painful; non-invasive LLLT treatment, such as the HairMax LaserComb, may be a more convenient option.

For women looking to prevent hair thinning and promote regrowth, female hair loss treatment is centred around an MHRA licensed and FDA approved topical medication which opens up potassium channels in the scalp – this is thought to stimulate follicles into accelerating hair growth.

Belgravia also offers complementary hair growth boosters as part of its customised treatment courses, where appropriate. These include clinical treatment therapy – which combines therapeutic scalp treatment, low-power laser therapy, infra red light therapy and massage – and the one-a-day premium food supplement, Hair Vitalics for Women. This contains key vitamins, minerals, amino acids and botanicals, including selenium, zinc and biotin which are known to promote healthy hair growth.

The estimated primary completion date of the study is May 2020, which may tell us more about the viability of PRP as a hair loss treatment going forward. If the therapy improves the quality of life of participants, then this would be another important finding, given the psychological effects losing hair can have on women.

However, the small scale of the study indicates much larger clinical trials would need to be conducted to find out how effective PRP may be more broadly.


Circ - womens hair loss treatment hair growth vitamins supplements hair vitalics belgravia centreThe Belgravia Centre

The Belgravia Centre is the leader in hair loss treatment in the UK, with two clinics based in Central London. If you are worried about hair loss you can arrange a free consultation with a hair loss expert or complete our Online Consultation Form from anywhere in the UK or the rest of the world. View our Hair Loss Success Stories, which are the largest collection of such success stories in the world and demonstrate the levels of success that so many of Belgravia’s patients achieve. You can also phone 020 7730 6666 any time for our hair loss helpline or to arrange a free consultation.


Related Stories


Researchers from the Francis Crick Institute in London and the University of Dundee have made a key scientific breakthrough which may have beneficial implications for hair loss and hair growth.

They examined the role of a protein called PAWS1 in the Wnt signalling pathways; these pathways pass signals into a cell which tell it how to function.

Because Wnt signalling pathways play such a vital role in bodily growth, mutations can often cause developmental defects and disease, ranging from cancer to hairloss. A study carried out by Stanford University in the US confirmed this notion, finding the Wnt signalling pathways to be critical for sustained hair growth.

Grant Hill, press officer at the University of Dundee, noted PAWS1 had the potential to address “potentially deleterious alterations to Wnt signalling”. This discovery may have key ramifications for hair loss treatments in the future.

PAWS1 breakthrough

Hill explained the researchers previously discovered PAWS1 is involved in a range of signalling processes involved in the development of bone, cartilage and other tissues in the human body”.

It is also crucial when shaping the development of embryos and determining the fate of cells in adults.

The Dundee-Crick team explored the molecular process through which PAWS1 controls Wnt signalling. This research was published in the EMBO Reports journal.

According to Hill, the research was conducted on frogs because “the activation of Wnt signalling in frog embryos is known to cause a two-headed tadpole”.

The findings revealed PAWS1 is a “crucial regulator” of the enzyme Caseine Kinase 1 alpha (CK1α) in Wnt signalling pathways.

PAWS1 mutations which were found to be incapable of effectively associating with the CK1α enzyme failed to produce two-headed tadpoles. They were also unable to activate Wnt signalling. Furthermore, when the team removed PAWS1 from a human osteosarcoma cell line (a malignant bone tumour), Wnt signalling was inhibited.

This suggests scientists may one day be able to correct alterations to Wnt signalling pathways in order to treat or prevent the diseases and conditions associated with it.

Hair growth implications

In a press release announcing the discovery, Professor Jim Smith of the Francis Crick Institute emphasises the protein’s role in hair growth: “Although the precise function of PAWS1 was poorly understood, PAWS1 mutations are known to cause palmoplantar hyperkeratosis, a disease in which there is excessive skin cell growth on the soles and palms and can affect normal hair growth leading to conditions such as alopecia”.

Smith continues “Wnt signalling is known to play crucial roles in the maintenance of skin tissue and hair development. Our findings… now offer an opportunity to establish whether the pathogenic PAWS1 mutations impact Wnt signalling to give rise to this disease”.

The hair loss condition to which Smith refers is unspecified – somewhat confusingly when the term ‘alopecia’ when used on its own simply means ‘hair loss’ without specificity. However, as other research in this area has tended to revolve around androgenetic alopecia – genetic hair loss, and particularly Male Pattern Baldness – this is likely to be the case here, though clarification has not been given.

Clinical trials are currently investigating a variety of stem cell based treatments for hereditary hair loss. A group of researchers funded by the US company Samumed has been trying to manipulate Wnt signalling pathways in the hope of encouraging new hair regrowth in cases of male pattern hairloss. RIKEN – a Japanese company – is also developing a cell regeneration method which would potentially allow artificial skin containing fully functioning hair follicles to be grafted into the scalps of people who are losing their hair from a number of conditions, including some which are currently untreatable, such as Cicatricial Alopecia.

While the work undertaken by the Dundee-Crick team reflects the huge potential presented by stem cell research in preventing baldness, this field is only just starting to be explored.

Given genetic hair loss is progressive, it is wise to address male and female pattern baldness sooner rather than later. Belgravia already treats these conditions, offering supportive, personalised treatment courses, which have produced many Success Stories to date. This approach provides on-going monitoring and uses clinically-proven, MHRA-licensed and FDA-approved medications which can be used alongside supplementary hair growth booster products as appropriate.


Belgravia Centre Hair Loss Clinic Hair Loss Specialist Free ConsultationThe Belgravia Centre

The Belgravia Centre is the leader in hair loss treatment in the UK, with two clinics based in Central London. If you are worried about hair loss you can arrange a free consultation with a hair loss expert or complete our Online Consultation Form from anywhere in the UK or the rest of the world. View our Hair Loss Success Stories, which are the largest collection of such success stories in the world and demonstrate the levels of success that so many of Belgravia’s patients achieve. You can also phone 020 7730 6666 any time for our hair loss helpline or to arrange a free consultation.


Related Stories


A series of children’s sci-fi adventure books – The Lucy Wilson Mysteries – celebrate diversity among young people, touching upon topics which range from race to hair loss.

The story’s protagonist, Lucy Wilson, is a girl of mixed-race heritage and the granddaughter of Doctor Who brigadier Alistair Lethbridge-Stewart. She is accompanied by her intelligent side-kick Hobo who experiences a form of Alopecia Areata.

The first story, Avatars of the Intelligence, was released in March 2018.

alopecia author‘Not defined by their condition’

In 1981 Sue Hampton, the author of the series, was diagnosed with Alopecia Universalis, an autoimmune disorder which is characterised as head-to-toe hairloss.

Her first story – The Waterhouse Girl – was inspired by her own experiences with the condition.

Talking to DoctorWhoNews.net, the author emphasises how writing helped her feel more comfortable about herself: “Writing The Waterhouse Girl changed my life, and changed the way I saw my alopecia. I began to feel braver, because my character was dealing with alopecia better than I was”.

She hopes The Lucy Wilson Mysteries series can help to normalise the experiences of children who may feel ‘different’:

“Since then [the release of The Waterhouse Girl] I’ve wanted to write stories where the characters are not defined by their condition, because that’s not what defines me. In Avatars of the Intelligence, Hobo does have alopecia, yes, but he is also loyal, brave and intelligent – all the qualities that Lucy needs in a friend”.

Hampton’s point – that children with hair loss should not be limited by their condition – is reinforced by the amount of positive and successful public figures who have Alopecia Areata. These include former Team GB cyclist Joanna Rowsell Shand and England rugby star Heather Fisher.

Diagram Belgravia Centre Different Types of Alopecia Areata autoimmune hair lossDealing with alopecia

Unfortunately treatment for Alopecia Areata on the scalp-only phenotype cannot be used by those younger than 16 years old. There are no treatments for Alopecia Totalis or Universalis which have proven to be both safe and effective, regardless of age.

The lack of options available to treat the condition, combined with the potential of bullying at school, can often leave children with hair loss stressed and isolated, a scenario explored in Hampton’s series.

As a result there are charities set up to cater specifically to children and young people experiencing hair loss. In the UK Little Princess Trust and Hero by LPT provide real-hair wigs for girls and boys experiencing medical forms of hairloss, including alopecia areata and cancer-related baldness, up to 24 years of age.

Hampton is a passionate ambassador for Alopecia UK: through her work with the charity she visits schools across the UK offering education and support.

In addition to this the charity gets involved in campaigning and fundraising efforts. Hampton previously raised over £750 by completing four hours of sponsored expressive dance. Rowsell Shand won £3,000 for the organisation on Celebrity Mastermind.

Many other peer support groups have been created, such as Molly’s Roots which was set up on Facebook by the mother of Molly Milligan, an 11-year-old with Alopecia Areata.

The work carried out by these charities, forums and figures try to make sure children with hair loss are given every opportunity to live with confidence and security. As demonstrated by Hampton’s characters, and by the author herself, losing hair needn’t be a barrier to a happy and successful life.


The Belgravia CentreThe Belgravia Centre

The Belgravia Centre is the leader in hair loss treatment in the UK, with two clinics based in Central London. If you are worried about hair loss you can arrange a free consultation with a hair loss expert or complete our Online Consultation Form from anywhere in the UK or the rest of the world. View our Hair Loss Success Stories, which are the largest collection of such success stories in the world and demonstrate the levels of success that so many of Belgravia’s patients achieve. You can also phone 020 7730 6666 any time for our hair loss helpline or to arrange a free consultation.


Related Stories